Devices › Prosthesis, hip, semi-constrained (metal cemented acetabular component)
Device brand name · Hip component
Lineage R Transcend R Superfinished Femoral Head: medical device reports filed with FDA
177 reports name it, 2010–2018. Manufacturer given most often on reports: Microport Orthopedics. Product code JDL.
- 177
- device reports naming the brand
- 0% of all MAUDE reports · about 11 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 0%
- classified as malfunction
- 1.2% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 177 reports that name the brand "Lineage R Transcend R Superfinished Femoral Head" (hip component), received between July 2010 and October 2018; the manufacturer given most often on reports is Microport Orthopedics. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all prosthesis, hip, semi-constrained (metal cemented acetabular component) reports (product code JDL) death is recorded in 0.2% and malfunction in 1.2%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are insufficient device problem information (36.2%), device dislodged or dislocated (19.2%) and break (2.8%). The patient problems coded most often are reaction, pain and joint dislocation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Lineage R Transcend R Superfinished Femoral Head was received in the five years to August 2026; the latest was received in October 2018.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 3,887 reports carrying product code JDL. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Insufficient device problem information | 64 | 36.2% | 44.2% |
| Device dislodged or dislocated | 34 | 19.2% | 5.7% |
| Breakthe device broke | 5 | 2.8% | 1.7% |
| Metal shedding debris | 5 | 2.8% | 4.2% |
| Corrodedthe device corroded | 4 | 2.3% | 3.8% |
| Detachment of device component | 4 | 2.3% | 0.4% |
| Loose or intermittent connection | 3 | 1.7% | 2.2% |
| Naturally worn | 3 | 1.7% | 7.6% |
| Noise, audible | 3 | 1.7% | 1.4% |
| Unstable | 3 | 1.7% | 0.9% |
| Material separation | 2 | 1.1% | 0.1% |
| Detachment of device or device componentpart of the device came off | 1 | 0.6% | 0.5% |
| Device markings/labelling problema problem with the device markings or label | 1 | 0.6% | 0% |
| Device slipped | 1 | 0.6% | 1.1% |
| Difficult to removethe device was hard to remove | 1 | 0.6% | 0.2% |
| Fracturea broken bone | 1 | 0.6% | 1.4% |
| Malposition of device | 1 | 0.6% | 1% |
| Material deformation | 1 | 0.6% | 0% |
| Material frayed | 1 | 0.6% | 0.1% |
| Migration or expulsion of device | 1 | 0.6% | 0.7% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Reactiona reaction, type not specified | 32 | 18.1% |
| Painpain, site not specified | 26 | 14.7% |
| Joint dislocationa dislocated joint | 10 | 5.6% |
| Bone fracture(s) | 2 | 1.1% |
| Falla fall | 2 | 1.1% |
| Hematomaa collection of blood under the skin or in tissue | 2 | 1.1% |
| Hip fracturea broken hip | 2 | 1.1% |
| Host-tissue reaction | 2 | 1.1% |
| Inflammationinflammation | 2 | 1.1% |
| Post operative wound infection | 2 | 1.1% |
| Test result | 2 | 1.1% |
| Toxicity | 2 | 1.1% |
| Arthralgiajoint pain | 1 | 0.6% |
| Dementiadementia | 1 | 0.6% |
| Joint disorder | 1 | 0.6% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Lineage R Transcend R Superfinished Femoral Head | Product code JDL | All MAUDE reports |
|---|---|---|---|
| Reports | 177 | 3,887 | 26,136,888 |
| Share of that pool | — | 4.6% | 0% |
| Classified as death, per 1,000 reports | 0 | 2 | 9 |
| Classified as injury | 100% | 98.1% | 36.2% |
| Classified as malfunction | 0% | 1.2% | 62.3% |
| Filed by the manufacturer | 100% | 98.9% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code JDL
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Conserve R Total A-Class Head | 1,369 | 0 | 0% |
| Dynasty R Cocr Liner | 270 | 0 | 0% |
| Head | 278 | 0 | 0% |
| Dynasty R A-Class R Poly Liner | 221 | 0 | 0.5% |
| Femoral Head | 303 | 11 | 0% |
| Conserve R Total Head W/Bfh | 465 | 0 | 0% |
| Enduron 10d 54od X 28id | 203 | 0 | 0% |
| Enduron 10d 56 Or 68odx28id | 159 | 2 | 0% |
| Femoral Head Biolox Delta | 170 | 0 | 0% |
| Conserve R Plus Cup | 1,328 | 0 | 0% |
| Enduron 10d 52od X 28id | 177 | 0 | 0% |
| Profemur R Modular Femoral Neck | 1,756 | 0 | 0.1% |
| Acetabular Component | 189 | 0 | 0% |
| Articul/Eze Ball 28 +8 5 Bl | 387 | 13 | 0.3% |
| Cocr Femoral Head | 175 | 4 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Lineage R Transcend R Superfinished Femoral Head reports
How many FDA reports name Lineage R Transcend R Superfinished Femoral Head?
177 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
insufficient device problem information (36.2%), device dislodged or dislocated (19.2%), break (2.8%), metal shedding debris (2.8%) and corroded (2.3%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Lineage R Transcend R Superfinished Femoral Head was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.